Khetemenee Lam
Pfizer (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Protein purification and stability, Viral Infectious Diseases and Gene Expression in Insects, T-cell and B-cell Immunology, Genomics and Chromatin Dynamics
Most-Cited Works
- → Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer(2016)94 cited
- → Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain(2012)86 cited
- → Transient CHO expression platform for robust antibody production and its enhanced N‐glycan sialylation on therapeutic glycoproteins(2018)44 cited
- → Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease(2020)28 cited
- → Quantitative Analysis of Target Coverage and Germinal Center Response by a CXCL13 Neutralizing Antibody in a T-Dependent Mouse Immunization Model(2013)20 cited
- → Genetic rearrangement during site specific integration event facilitates cell line development of a bispecific molecule(2021)13 cited
- → Author response for "Genetic Rearrangement During Site Specific Integration Event Facilitates Cell Line Development of a Bispecific Molecule"(2021)